Medical Services International Inc. Begins Active Marketing Program in Western Countries for its Rapid Test for Tuberculosis
July 10 2007 - 2:16PM
PR Newswire (US)
EDMONTON, Alberta, July 10 /PRNewswire-FirstCall/ -- Medical
Services International Inc. (Pink Sheets: MSITF) wishes to announce
that it has begun a very active marketing program for its VScan TB
rapid test kit in Western countries. As part of this program, the
Company is looking for a partner in the United States to begin the
process of applying for regulatory approval in the United States.
The Company has done significant testing of its VScan rapid test
kit for TB and is confident that its test data will be acceptable.
The VScan TB test kit is already approved in several Eastern Europe
countries as well as Southeast Asia. Should the VScan TB test kit
be approved for use in North America, the Company believes that the
demand will be significant, increasing the Company's overall
financial performance. It becomes obvious that TB is increasing in
North America. Recent events that the public were made aware of was
the individual flying into Montreal, Canada from Prague with active
TB and an individual with active TB entering a Day Care Facility in
Edmonton, Alberta on July 9, 2007 to pick up children. While the
Capital Health Authority of Edmonton has indicated that exposure in
this case was very low risk, it shows that Tuberculosis (TB) is in
the general population and is being spread. What the Capital Health
authority did not address is the exposure to the children that were
being picked up. According to the World Health Organization, TB
will kill over 8 million people this year. TB is the most
infectious disease currently prevalent throughout the world.
Current testing procedures are inaccurate and give false positives
30% of the time. The VScan TB test kit gives no false positives
(100% Specificity) and during independent testing has shown an
accuracy of over 85%. There is no other test that is as accurate as
the VScan TB test kit. The key to controlling the spread of
Tuberculosis is rapid, accurate testing so that treatment can begin
immediately. TB is transmitted through the droplets that result
from an individual coughing. About VScan The VScan rapid test kit
is a single use, easy to use, accurate test for the screening of
HIV 1&2, Hepatitis B&C, Malaria, Dengue Fever, West Nile,
Syphilis, and Prostate Cancer. The kits cannot be sold in Canada.
Medical Services International Inc. trades in the United States on
the NQB Pink Sheets under the symbol "MSITF". For further
information, please contact Robert Talbot at (780) 430 6363 or
http://www.medicalservicesintl.com/ or
http://www.minerva-biotech.com/ NOTE: Certain statements in this
press release are "forward-looking statements" within the meaning
Private Securities Act of 1885. Such statements involve known and
unknown risks, uncertainties and other factors that may cause
results to differ materially. Such risks, uncertainties and other
factors include but are not limited to new economic conditions,
risk in product development, market acceptance of new products and
continuing product demand, level of competition and other factors
described in Company reports and other filings with regulatory
bodies. DATASOURCE: Medical Services International Inc. CONTACT:
Robert Talbot of Medical Services International Inc.,
+1-780-430-6363 Web site: http://www.medicalservicesintl.com/
http://www.minerva-biotech.com/
Copyright